Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1224-1231 , November 2009

The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: Lessons learned and anticipated results

  • Brajesh K. Lal, MD

      Affiliations

    • Division of Vascular Surgery, University of Maryland Medical Center, Baltimore, Md
    • ,
  • Thomas G. Brott, MD

      Affiliations

    • CREST Administrative Center, University of Medicine and Dentistry New Jersey-New Jersey Medical School, Newark, NJ
    • Department of Neurology, Mayo Clinic, Jacksonville, Fla
    • Corresponding Author InformationReprint requests: Thomas G. Brott, MD, Mayo Clinic, Griffin Building, 3rd Floor, 4500 San Pablo Rd., Jacksonville, FL 32224

Received 1 September 2009 ,Accepted 2 September 2009.

  • Image Result

    (A) The RX Acculink stent. (B) The RX Accunet embolic protection system.

    (A) The RX Acculink stent. (B) The RX Accunet embolic protection system.

  • Image Result

    The distribution of interventionalists by medical specialty who were credentialed for the randomized phase of CREST.

    The distribution of interventionalists by medical specialty who were credentialed for the randomized phase of CREST.

  • Image Result

    The 30-day rate of any stroke or death by age cohorts.

    The 30-day rate of any stroke or death by age cohorts.

  • Image Result

    The location of the randomizing sites in CREST.

    The location of the randomizing sites in CREST.

  • Image Result

    The randomization into CREST by symptomatic status over time.

    The randomization into CREST by symptomatic status over time.

  • Image Result

    (A) Important milestones and challenges leading up to the inclusion of asymptomatic patients in CREST. (B) The recent and upcoming milestones in the culmination of the randomized phase of CREST.

    (A) Important milestones and challenges leading up to the inclusion of asymptomatic patients in CREST. (B) The recent and upcoming milestones in the culmination of the randomized phase of CREST.

 Supported by National Institute of Neurological Disorders and Stroke-National Institutes of Health (NINDS-NIH) RO1 NS 038384. Additional funding was provided by Abbott Vascular.

 Competition of interest: none.

PII: S0741-5214(09)01833-3

doi: 10.1016/j.jvs.2009.09.003

Journal of Vascular Surgery
Volume 50, Issue 5 , Pages 1224-1231 , November 2009

Article Tools

* Image Usage & Resolution